Literature DB >> 23051886

Relationships between physical fitness, physical activity, smoking and metabolic and mental health parameters in people with schizophrenia.

Davy Vancampfort1, Michel Probst, Thomas Scheewe, Amber De Herdt, Kim Sweers, Jan Knapen, Ruud van Winkel, Marc De Hert.   

Abstract

Low physical fitness has been recognised as a prominent behavioural risk factor for cardiovascular diseases (CVD) and metabolic syndrome (MetS), and as an independent risk factor for all-cause mortality. No studies have systematically assessed physical fitness compared with a matched health control group in patients with schizophrenia. Eighty patients with schizophrenia and 40 age-, gender- and body mass index (BMI)-matched healthy volunteers were included. All participants performed an Eurofit test battery and filled out the International Physical Activity Questionnaire. Patients additionally had a fasting metabolic laboratory screening and were assessed for psychiatric symptoms. Patients with schizophrenia demonstrated significant differences from controls in whole body balance, explosive leg muscle strength, abdominal muscular endurance, and running speed. Inactive patients scored worse on most Eurofit items than patients walking for at least 30min per day. Low physical fitness was associated with illness duration, smoking, the presence of MetS and more severe negative, depressive and cognitive symptoms. Less physically active patients who smoke and suffer from high levels of negative, depressive and/or cognitive symptoms might benefit from specific rehabilitation interventions aimed at increasing physical fitness.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23051886     DOI: 10.1016/j.psychres.2012.09.026

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  36 in total

1.  Relationship between whether the planned discharge destination is decided and locomotive syndrome for admitted patients in psychiatric long-term care wards.

Authors:  Munetsugu Kota; Sae Uezono; Yusuke Ishibashi; Sousuke Kitakaze; Hideki Arakawa
Journal:  Phys Ther Res       Date:  2020-08-20

2.  Relationship between motor function and psychotic symptomatology in young-adult patients with schizophrenia.

Authors:  Shu-Mei Wang; Wen-Chen Ouyang; Ming-Yi Wu; Li-Chieh Kuo
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-04-11       Impact factor: 5.270

3.  Sedentary behavior and psychiatric symptoms in overweight and obese adults with schizophrenia and schizoaffective disorders (WAIST Study).

Authors:  Carol A Janney; Rohan Ganguli; Caroline R Richardson; Rob G Holleman; Gong Tang; Jane A Cauley; Andrea M Kriska
Journal:  Schizophr Res       Date:  2013-02-12       Impact factor: 4.939

4.  Meta-analysis of physical activity and effects of social function and quality of life on the physical activity in patients with schizophrenia.

Authors:  Kazutaka Ohi; Yuzuru Kataoka; Takamitsu Shimada; Aki Kuwata; Hiroaki Okubo; Kohei Kimura; Toshiki Yasuyama; Takashi Uehara; Yasuhiro Kawasaki
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-05-22       Impact factor: 5.270

5.  The animated assessment of theory of mind for people with schizophrenia (AToMS): development and psychometric evaluation.

Authors:  Ya-Chin Yeh; Chi-Fa Hung; Chung-Ying Lin; Yuh-Yih Wu; Chun-Hong Kuo; Marc N Potenza; Chun-Hua Cheng; Kuan-Lin Chen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-10-18       Impact factor: 5.760

6.  Recommendations of the Schizophrenia Expert Center network for adequate physical activity in real-world schizophrenia (FACE-SZ).

Authors:  Pierre-Louis Sunhary De Verville; Brendon Stubbs; Damien Etchecopar-Etchart; Ophélia Godin; Christelle Andrieu-Haller; Fabrice Berna; Bruno Aouizerate; Delphine Capdevielle; Isabelle Chereau; Julie Clauss-Kobayashi; Nathalie Coulon; Jean-Michel Dorey; Caroline Dubertret; Sylvain Leignier; Jasmina Mallet; David Misdrahi; Catherine Passerieux; Baptiste Pignon; Romain Rey; Mathieu Urbach; Pierre-Michel Llorca; Franck Schürhoff; Christophe Lançon; Laurent Boyer; Guillaume Fond
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-04-20       Impact factor: 5.760

7.  A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls.

Authors:  Davy Vancampfort; Martien Wampers; Alex J Mitchell; Christoph U Correll; Amber De Herdt; Michel Probst; Marc De Hert
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

8.  Factors Affecting the Management of Somatic Comorbidity in Tunisian Patients with Schizophrenia.

Authors:  Jihene Ben Thabet; Nada Charfi; Wafa Dalhoum; Sourour Yaich; Manel Maâlej Bouali; Sana Omri; Nasreddine Zouari; Lobna Zouari; Jamel Damak; Mohamed Maâlej
Journal:  Psychiatr Q       Date:  2019-03

9.  Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia.

Authors:  Junji Saruwatari; Norio Yasui-Furukori; Ryoko Kamihashi; Yuki Yoshimori; Kentaro Oniki; Shoko Tsuchimine; Madoka Noai; Yasushi Sato; Taku Nakagami; Norio Sugawara; Manabu Saito; Akira Fujii; Ayami Kajiwara; Shuichi Mihara; Yasuhiro Ogata; Sunao Kaneko; Kazuko Nakagawa
Journal:  Neuropsychiatr Dis Treat       Date:  2013-11-01       Impact factor: 2.570

10.  Body mass index and quality of life among outpatients with schizophrenia in Japan.

Authors:  Norio Sugawara; Norio Yasui-Furukori; Yasushi Sato; Manabu Saito; Hanako Furukori; Taku Nakagami; Shuhei Kudo; Sunao Kaneko
Journal:  BMC Psychiatry       Date:  2013-04-09       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.